B-cell Lymphoma

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Normal Subjects and Disorders of Immune System and Cancer

Recruiting
  • T-cell Lymphoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

    Recruiting
    • Follicular Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia Trial in United States (Ublituximab)

    Completed
    • Non-Hodgkins Lymphoma
    • +6 more
    • Huntsville, Alabama
    • +7 more
    Oct 1, 2019

    B-Cell Lymphoma, B-Cell Leukemia Trial in United States (PCI-32765)

    Completed
    • B-Cell Lymphoma
    • B-Cell Leukemia
    • Palo Alto, California
    • +8 more
    May 21, 2013

    B-Cell Lymphoma Trial in Bethesda, Buffalo (PS-341, Etoposide, Doxorubicin)

    Completed
    • B-Cell Lymphoma
    • Bethesda, Maryland
    • +1 more
    Aug 10, 2012